US Stock MarketDetailed Quotes

FBRX Forte Biosciences

Watchlist
  • 11.940
  • -0.060-0.50%
Trading Feb 18 11:06 ET
76.34MMarket Cap-0.73P/E (TTM)

Forte Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Forte Biosciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Forte Biosciences Earnings Reports

  • Forte Biosciences | 8-K: FORTE BIOSCIENCES, INC. ANNOUNCES THIRD QUARTER 2024 RESULTS AND PROVIDES BUSINESS UPDATE

    Nov 14, 2024 17:24 ET

  • Forte Biosciences | 10-Q: Q3 2024 Earnings Report

    Nov 14, 2024 16:14 ET

  • Forte Biosciences | 8-K: FORTE BIOSCIENCES, INC. ANNOUNCES SECOND QUARTER 2024 RESULTS AND PROVIDES BUSINESS UPDATE

    Aug 14, 2024 16:44 ET

  • Forte Biosciences | 10-Q: Q2 2024 Earnings Report

    Aug 14, 2024 16:12 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Constellation Brands
    STZ
    +5.09%
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +4.97%
    New Fortress Energy
    NFE
    +4.73%
    Lantheus
    LNTH
    +3.27%
    DexCom
    DXCM
    +3.17%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 21, 2025

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data